Latham & Watkins’ The New Antitrust Era webcast series provides key insights into the evolution of regulatory enforcement and private actions in the global competition landscape.
In this installment, Latham’s Global Antitrust & Competition practitioners, including the former Director of the Bureau of Competition at the US Federal Trade Commission, offer guidance for navigating the most prevalent issues facing the life sciences industry around the world.
Topics
- Mergers: shifting guidelines, recent trends, what to watch out for with remedies, and lessons learned
- Regulatory enforcement: restricted distribution structures, market allocation, patent settlements, and product hopping
- Counseling: structuring deals and risk allocation, licensing and exclusive arrangements, and distribution agreements
Speakers
Mandy Reeves, Partner and Global Chair of the Antitrust & Competition Practice, Washington, D.C.
Héctor Armengod, Partner, Brussels
Ian Conner, Partner, Washington, D.C.
Patrick English, Counsel, Washington, D.C.
Thank you for your interest. Please provide your contact information below to register for this webcast. A confirmation e-mail with access to the recording and presentation materials will be sent upon completion. This webcast was originally presented on March 30, 2022.
Already registered? Click here.